Enter assignee name

EPO Patents = 1

Forward Citations = 128

Loading Chart...

11 inventors (with patents filed for the assignee):

Jeffrey Alan Stafford (9 out of 141 patents)

James Marvin Veal (8 out of 104 patents)

Zhe Nie (5 out of 47 patents)

4. Toufike Kanouni (5 out of 85 patents)

5. Young K Chen (4 out of 63 patents)

6. Michael Brennan Wallace (4 out of 94 patents)

7. Stephen W Kaldor (2 out of 66 patents)

8. Amogh Boloor (2 out of 33 patents)

9. Michael John Bennett (2 out of 11 patents)

10. Michael Brennen Wallace (2 out of 2 patents)

11. Juan Manuel Betancort (1 out of 19 patents)

10 patents: Sort by Forward Citations

1. 9255097 - Inhibitors of lysine specific demethylase-1 (2016-02-09),

2. 9242968 - Histone demethylase inhibitors (2016-01-26),

3. 9133166 - Histone demethylase inhibitors (2015-09-15),

4. 9115114 - Bromodomain inhibitors (2015-08-25),

5. 9107916 - Histone demethylase inhibitors (2015-08-18),

6. 9085534 - Histone demethylase inhibitors (2015-07-21),

7. 9034900 - Bromodomain inhibitors (2015-05-19),

8. 8987461 - Histone demethylase inhibitors (2015-03-24),

9. 8969343 - Histone demethylase inhibitors (2015-03-03),

10. 8952151 - Histone demethylase inhibitors (2015-02-10),

Quanticel Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of targeted cancer therapies. They utilize cutting-edge technologies to identify novel drug targets and develop precision medicine solutions for patients. Quanticel is dedicated to advancing the field of oncology through innovative research and strategic partnerships.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#506 in San Diego, CA

#6,897 in California

#29,007 in US

#54,325 in the World

San Diego, CA, United States of America

Quanticel Pharmaceuticals, Inc.